These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 38690712)
1. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells. Abou Nader N; Charrier L; Meisnsohn MC; Banville L; Deffrennes B; St-Jean G; Boerboom D; Zamberlam G; Brind'Amour J; Pépin D; Boyer A FASEB J; 2024 May; 38(9):e23633. PubMed ID: 38690712 [TBL] [Abstract][Full Text] [Related]
2. Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774 [TBL] [Abstract][Full Text] [Related]
3. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation. Wu Y; Qin K; Xu Y; Rajhans S; Vo T; Lopez KM; Liu J; Nipper MH; Deng J; Yin X; Ramjit LR; Ye Z; Luan Y; Arda HE; Wang P Elife; 2024 Jul; 13():. PubMed ID: 39051998 [TBL] [Abstract][Full Text] [Related]
4. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate. Abou Nader N; Ménard A; Levasseur A; St-Jean G; Boerboom D; Zamberlam G; Boyer A Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362374 [TBL] [Abstract][Full Text] [Related]
5. Hippo-YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass. Choi S; Kang JG; Tran YTH; Jeong SH; Park KY; Shin H; Kim YH; Park M; Nahmgoong H; Seol T; Jeon H; Kim Y; Park S; Kim HJ; Kim MS; Li X; Bou Sleiman M; Lee E; Choi J; Eisenbarth D; Lee SH; Cho S; Moore DD; Auwerx J; Kim IY; Kim JB; Park JE; Lim DS; Suh JM Nat Metab; 2024 May; 6(5):847-860. PubMed ID: 38811804 [TBL] [Abstract][Full Text] [Related]
7. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557 [TBL] [Abstract][Full Text] [Related]
8. Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target. Suto H Anticancer Res; 2024 Oct; 44(10):4147-4153. PubMed ID: 39348982 [TBL] [Abstract][Full Text] [Related]
9. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
10. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers. Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis. Mohad V; Lungova V; Verheyden J; Thibeault SL Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576 [TBL] [Abstract][Full Text] [Related]
12. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis. Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529 [TBL] [Abstract][Full Text] [Related]
13. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice. Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M; Wang M; Xu S; Guo X; Jiang J Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204 [TBL] [Abstract][Full Text] [Related]
15. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073 [TBL] [Abstract][Full Text] [Related]
16. Heat stress activates YAP/TAZ to induce the heat shock transcriptome. Luo M; Meng Z; Moroishi T; Lin KC; Shen G; Mo F; Shao B; Wei X; Zhang P; Wei Y; Guan KL Nat Cell Biol; 2020 Dec; 22(12):1447-1459. PubMed ID: 33199845 [TBL] [Abstract][Full Text] [Related]
17. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
18. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate. Ménard A; Abou Nader N; Levasseur A; St-Jean G; Le Roy MLG; Boerboom D; Benoit-Biancamano MO; Boyer A Endocrinology; 2020 May; 161(5):. PubMed ID: 32243503 [TBL] [Abstract][Full Text] [Related]
19. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors. Akrida I; Makrygianni M; Nikou S; Mulita F; Bravou V; Papadaki H Pathol Res Pract; 2024 Oct; 262():155551. PubMed ID: 39153238 [TBL] [Abstract][Full Text] [Related]
20. Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway. Vanyai HK; Prin F; Guillermin O; Marzook B; Boeing S; Howson A; Saunders RE; Snoeks T; Howell M; Mohun TJ; Thompson B Development; 2020 Nov; 147(21):. PubMed ID: 32994166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]